us. for afternoon, and thank good and Jody, you everyone, joining Thanks,
move we company. progress to have continued exceptional toward the dissolution We as make of
We we by forward transaction the indeed turn productive. since to recapping weeks Please quarter and monetizing our recent discuss conference in announced in where last process are assets begin of were X. quarterly past then and very This path company. remaining will the the dissolving call and Slide our
sale the business Noden closing spin-off With businesses. of October the we PDL’s our completed September LENSAR and our the stockholders of pharmaceutical the to monetization of Xst, in of on operating
our a Our CARES entered provided benefits PDL by a take simplified tax with of closure we into important We remaining this that Wellstat royalties the to settlement on placed Holdings collect of of enable sale Act. confident agreement the portfolio position are and to us this a in August basket and SWK considerably receivable. will reach to asset advantage and in agreement
sale the in Under terms originally convert our higher to quarter closing will the million payment only $X.X Noden to We of business notes. this remaining cash incremental $XX.X value $XX.XX DAC the the of dates. which closing. $XXX period, to with original We equity in to $XX.X wholly-owned between million announced received notes Noden and than Noden signing million million representing with in notes with and of the we XXXX we X. remain of Pharma closed payments XXXX, December the notices transaction anticipated on partnership transaction, we an transaction the July PDL to is total the to Capital. this up In convertible aggregate outstanding. September, our XXXX XXXX Pharma up in of of private par due Stanley the convertible primarily $X.X After announced, Slide the received USA and conversion accumulated in this agreement of value million. closed early Starting upon Finally, previously late due third subsidiaries $XX.XX million XX% of million, this
in XXXX. VAT XX An additional and also in will of distributed equal to future from provides an January for to XXXX million. to anticipate quarterly is $X.XX October installments post-dissolution The which installments quarterly three be four to a PDL million period, additional processed from year We to potential in that due our are to to $X.XX totaling October these reimbursement additional receive will We and during paid January for XXXX I two stockholders contingent transaction million XXXX payments paid equal PDL million XXXX. payments an discuss be moment. in to $XX $X.XX be
losses executing a this advisors, proceeds in from and to ordinary recognize the CARES applied wish to will in to which tax XXXX, Leerink benefit along tax net years greater Act. or of Torreya Act Ed I in with tax connection in and arising management years law was believe moment. PDL's into CARES our late to taxpayer. be March could prior XXXX substantial years SVB the board was directors carry thank passed the our this with the in In qualify a taxable our detail In Noden PDL monetization for under the taxpayers expect team that transaction. Partners permits the discuss for we we Act may five financial The back any beginning sale, cash transaction to and addition in losses ordinary under some process, federal XXXX. CARES
You to in Leerink may PDL Torreya Noden and recall to SVB distribution of strategic by strategies. while that on the overall engaged transactions assist then disposition explore liquidation was was advice and potential retained
Turning to X. on Slide LENSAR
reached of is dividend decision Biosciences LENSAR proved Xst the form spin-off to spin-off to Similar to LENSAR our their assets the traded Leerink, share Net in the publicly serve shares attributable to Following distribution stockholders stock. million. outstanding $XXX.X entity a to Evofem own stockholders. to May on very affected common in our next-generation the We holding distribution believe that stockholders PDL's investment becoming We well growth share appropriately by PDL on prior to October LENSAR in ALLY, a the all that and of resume holders the XXXX COVID-XX. of LANSAR of the NASDAQ. development We involving comprehensive one-day their PDL of LENSAR positioned trajectory pursue were held be strategic September XX, the post a completed partnership system, SVB will in process conducted distribution LENSAR. on decision XX% to PDL's to regarding board in with it and distribution its well, last to our its that launch reach resourced PDL's enables
loans of Parties be the shall million were and as Parties carried in settlement million under PDL the balance July XXXX quarter. have XXXX XX, agreement made X, February payment Wellstat Parties of paid made by and million be XX, PDL. the end $XX.X XX, July or The million loans Wellstat the Parties either failed and relating by judgment as litigation were the in of by XXXX If to million $XX.X sheet Wellstat announced the PDL's or option notes on second full $X the Now a agreement of to at July an previously $XX.X time we the record to Slide totaling the agreement. signing. may for by paying for amount this terms million the reported August owed August $XX Under $X.X paying $XX.X authorized Diagnostics to of Wellstat against by the resolving to The the past on of settlement lesser make XXXX, company a XXXX. million XX, confess amount Wellstat
litigation comment Parties. our I be reached to very to this the We settlement legal in have are PDL at Wellstat with pleased tenacity the pleased, resolution. Wellstat for successful their bringing team
review to for the on million of SWK now Holdings Coflex Corporation Slide our $X.XX progress in we our August, cash. rights Let's sale Zalviso In Kybella, royalty royalty and with assets X. announced
the qualify under believe transaction to addition proceeds In the the CARES to from benefit SWK, sale for Act. also federal cash may this we tax
Jentadueto portfolio $XX.X $XX.X Invokamet well royalty have These royalties cash XR QX and interest collectively in of of are performed XR, Our Synjardy well in remaining million Cerdelga. earnings $XX.X which called remaining million and as royalties in in versus XR, QX Glumetza, royalty our QX year. generating Assertio this million as includes
to be commercializing is of unable Evofem for Evofem can continue we’re time, our assets evaluate this share sale assets may value warrant Evofem of Alternatively, the exercised ultimately distribute of warrants a for share. these Securities. of common to stock hold at prevention advisement each BofA million stockholders. early We we X.X X sale pregnancy. of retain appropriate these Phexxi a for secure phase and $X.XX if per in high-value at royalty the to the We under revenues
our at are stockholders. the will the Evofem the determine We and value maximize time monitoring of the disposition for warrants we believe will we
in pleased support filed held receive to Meeting we X. with of At Certificate Turning approval XXXX. the am allow for of January board file steps of August, proposal announced announce decided Dissolution Annual to has our to the operations. overwhelming stockholders Slide believe pleased stockholders this close the the to on for our I have a of as We efficient now Delaware. that for of we PDL company's the wind-down to Certificate XXXX will were Dissolution very of State on X, the next
claims of the PDL and for Let our wind-down potential in points three liquidation its disputes, managing to any existence and remaining a will which purposes, release. Law, filing any me the distributing highlight Certificate after process. solely dissolution Per continue associated monetizing proceeds of stockholders resolving including: process, minimum its with Delaware a few litigations, Dissolution important of noted the of earnings we years for assets
and longer. the liability Harbor to procedures are Law note the making against form PDL to aside be company's But work the Safe the Court and to Generally tax future take stockholders, report PDL XX XX is determine Under no resources will and California Upon to stockholders. distribution SEC monetization liabilities potential procedures of to the reduce and Franchise Chancery enter longer Delaware XX claims. contingent Safe including amount could to we'll continue reduce company. made Safe but following Harbor to distributions distribute to of security and also reduce are Procedures Safe the a PDL before Dissolution tax remaining the the returns procedures will that remaining Harbor procedures. months Harbor anticipate year overhead to set unknown complete, the as Safe before are continue first distributions the plan likely company. will made Tax of operating of important stockholders to require for even we will Delaware dissolution. before in usually The we the the that audit take procedures, it follow completed. return, PDL Safe public XXXX our to we importantly, of that expenses the dissolution, various company Board. resolve months the the assets Harbor for be to emphasize PDL's the to and hard appropriate the allow stockholders. to completion the petition by stockholders from PDL's we It do Harbor any XX the Safe our the of through to to Before resolution current The we of assets procedures, directors claims the issues filing complete Harbor of XXXX will and not expense,
after engage XXXX. NASDAQ OTC with into do market We of delisting stock transferring the common we will XX, anticipate close December regarding on not trading. company's Finally, the
X, mentioned as the PDL's record anticipated It book to as made stockholders of Record Our will distribution and be close is Final No occur stock of the filing this XXXX, the made Date. after the that will common as will January Final will further be final Date. expected pro record of certificate occur date. of to the any in on Record of transfer with the of connection dissolution trading the rata dissolution,
Turning X. to Slide
shifted the dissolution X. of accounting As to our financial reporting of starting the will basis approval the on September liquidation Ed discuss of plan of
to PDL's LENSAR net prior were me top-lines Net in provide the were of million. net the just liquidation LENSAR to our Let on quarter, spin-off, million. assets September in liquidation. $XXX.X end XXth assets $XXX.X assets of third attributable At the
PDL's were So or liquidation net common in LENSAR's share per liabilities, million PDL assets stock $X.XX and of outstanding. assets excluding $XXX.X
to our able to Of value course, will distribute and this stockholders, capture but it there no is remains this be guarantee that focus. we our fully
over Ed? Imbrogno turn details. greater to the to our to like call financials discuss Ed in I'd Now,